




*SEVEN® Plus Users Guide
†Brauker J, Kamath A, Mahalingam A. Analysis of Time Lags and Other Sources of Error of the DexCom SEVEN Continuous Glucose Monitor. Diabetes Technology & Therapeutics. 2009;11:689-695.
BRIEF SAFETY STATEMENT
The SEVEN® PLUS Continuous Glucose Monitoring System is a glucose monitoring device indicated for detecting trends and tracking patterns in adults (age 18 and older) with diabetes. The device is for prescription use only.
CONTRAINDICTIONS: The SEVEN® PLUS System must be removed prior to Magnetic Resonance Imaging (MRI). Use of acetaminophen-containing medications during Sensor wear may affect device performance.
WARNING: This device is not designed to replace a blood glucose meter. Always confirm with a blood glucose meter. Sensors fracture on rare occasions. If a sensor breaks and no portion of it is visible above the skin, do not attempt to remove it. Seek professional medical help if you have symptoms of infection or inflammation. If you experience a broken sensor, please report this to our Technical Support department. The SEVEN® and SEVEN® PLUS Systems are not approved for use in children or adolescents, pregnant women or persons on dialysis. The safety and effectiveness of the SEVEN® and SEVEN® PLUS Systems have not been evaluated for sensor probe insertion sites other than the skin of the abdomen.
Contact DexCom Toll Free at 877-339-2664 or www.dexcom.com for detailed indications for use and safety information.